Cargando…

Effect of Oral Vitamin D3 Supplementation in Exclusively Breastfed Newborns: Prospective, Randomized, Double‐Blind, Placebo‐Controlled Trial

Exclusively breastfed infants are at a high risk of vitamin D deficiency. Few studies have evaluated the effects of vitamin D supplementation. Hence, we conducted a prospective randomized controlled trial investigating the effects of oral vitamin D3 400 IU/d supplementation in exclusively breastfed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chao‐Hsu, Lin, Chien‐Yu, Sung, Yi‐Hsiang, Li, Sung‐Tse, Cheng, Bi‐Wen, Weng, Shun‐Long, Chang, Shing‐Jyh, Lee, Hung‐Chang, Lee, Yann‐Jinn, Ting, Wei‐Hsin, Chang, Hung‐Yang, Wu, Yi‐Lei, Lin, Chih‐Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306990/
https://www.ncbi.nlm.nih.gov/pubmed/35122668
http://dx.doi.org/10.1002/jbmr.4521
_version_ 1784752667864596480
author Lin, Chao‐Hsu
Lin, Chien‐Yu
Sung, Yi‐Hsiang
Li, Sung‐Tse
Cheng, Bi‐Wen
Weng, Shun‐Long
Chang, Shing‐Jyh
Lee, Hung‐Chang
Lee, Yann‐Jinn
Ting, Wei‐Hsin
Chang, Hung‐Yang
Wu, Yi‐Lei
Lin, Chih‐Sheng
author_facet Lin, Chao‐Hsu
Lin, Chien‐Yu
Sung, Yi‐Hsiang
Li, Sung‐Tse
Cheng, Bi‐Wen
Weng, Shun‐Long
Chang, Shing‐Jyh
Lee, Hung‐Chang
Lee, Yann‐Jinn
Ting, Wei‐Hsin
Chang, Hung‐Yang
Wu, Yi‐Lei
Lin, Chih‐Sheng
author_sort Lin, Chao‐Hsu
collection PubMed
description Exclusively breastfed infants are at a high risk of vitamin D deficiency. Few studies have evaluated the effects of vitamin D supplementation. Hence, we conducted a prospective randomized controlled trial investigating the effects of oral vitamin D3 400 IU/d supplementation in exclusively breastfed newborns. Serum 25‐hydroxy‐vitamin D (25[OH]D) levels in pregnant women and their newborns were evaluated. Breastfed newborns were randomized to one of two regimens at age 10 days. One group received vitamin D3 supplementation at a dose of 400 IU/d (vD‐400 group), whereas the placebo group received a liquid product without vitamin D3. Outcomes were assessed at 4 months of age. A total of 92 pregnant women and their infants were enrolled, and the data of 72 infants (37 in the vD‐400 group and 35 in the placebo group) who completed the study at 4 months of age were assessed. The results showed severe vitamin D deficiency in 15.2% of mothers before delivery, while 54.3% had vitamin D deficiency. Moreover, 15.2% of newborns presented with severe vitamin D deficiency at birth, while 52.2% had vitamin D deficiency. Maternal vitamin D levels were significantly correlated with infant vitamin D levels at birth (r = 0.816, p < 0.001). At 4 months of age, weight, head circumference, serum 25(OH)D, phosphorus, and intact parathyroid hormone levels significantly differed between the vD‐400 and placebo groups. However, the body length and bone mineral density of the two groups did not differ significantly. Regardless of vitamin D supplementation, participants with severe vitamin D deficiency had significantly higher intact parathyroid hormone levels and lower bone mineral content. In conclusion, among exclusively breastfed infants, oral supplementation with vitamin D3 at a dose of 400 IU/d from age 10 days increased 25(OH)D concentrations at 4 months of age, but it did not affect bone mineralization. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
format Online
Article
Text
id pubmed-9306990
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-93069902022-07-28 Effect of Oral Vitamin D3 Supplementation in Exclusively Breastfed Newborns: Prospective, Randomized, Double‐Blind, Placebo‐Controlled Trial Lin, Chao‐Hsu Lin, Chien‐Yu Sung, Yi‐Hsiang Li, Sung‐Tse Cheng, Bi‐Wen Weng, Shun‐Long Chang, Shing‐Jyh Lee, Hung‐Chang Lee, Yann‐Jinn Ting, Wei‐Hsin Chang, Hung‐Yang Wu, Yi‐Lei Lin, Chih‐Sheng J Bone Miner Res Original Articles Exclusively breastfed infants are at a high risk of vitamin D deficiency. Few studies have evaluated the effects of vitamin D supplementation. Hence, we conducted a prospective randomized controlled trial investigating the effects of oral vitamin D3 400 IU/d supplementation in exclusively breastfed newborns. Serum 25‐hydroxy‐vitamin D (25[OH]D) levels in pregnant women and their newborns were evaluated. Breastfed newborns were randomized to one of two regimens at age 10 days. One group received vitamin D3 supplementation at a dose of 400 IU/d (vD‐400 group), whereas the placebo group received a liquid product without vitamin D3. Outcomes were assessed at 4 months of age. A total of 92 pregnant women and their infants were enrolled, and the data of 72 infants (37 in the vD‐400 group and 35 in the placebo group) who completed the study at 4 months of age were assessed. The results showed severe vitamin D deficiency in 15.2% of mothers before delivery, while 54.3% had vitamin D deficiency. Moreover, 15.2% of newborns presented with severe vitamin D deficiency at birth, while 52.2% had vitamin D deficiency. Maternal vitamin D levels were significantly correlated with infant vitamin D levels at birth (r = 0.816, p < 0.001). At 4 months of age, weight, head circumference, serum 25(OH)D, phosphorus, and intact parathyroid hormone levels significantly differed between the vD‐400 and placebo groups. However, the body length and bone mineral density of the two groups did not differ significantly. Regardless of vitamin D supplementation, participants with severe vitamin D deficiency had significantly higher intact parathyroid hormone levels and lower bone mineral content. In conclusion, among exclusively breastfed infants, oral supplementation with vitamin D3 at a dose of 400 IU/d from age 10 days increased 25(OH)D concentrations at 4 months of age, but it did not affect bone mineralization. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). John Wiley & Sons, Inc. 2022-02-21 2022-04 /pmc/articles/PMC9306990/ /pubmed/35122668 http://dx.doi.org/10.1002/jbmr.4521 Text en © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Lin, Chao‐Hsu
Lin, Chien‐Yu
Sung, Yi‐Hsiang
Li, Sung‐Tse
Cheng, Bi‐Wen
Weng, Shun‐Long
Chang, Shing‐Jyh
Lee, Hung‐Chang
Lee, Yann‐Jinn
Ting, Wei‐Hsin
Chang, Hung‐Yang
Wu, Yi‐Lei
Lin, Chih‐Sheng
Effect of Oral Vitamin D3 Supplementation in Exclusively Breastfed Newborns: Prospective, Randomized, Double‐Blind, Placebo‐Controlled Trial
title Effect of Oral Vitamin D3 Supplementation in Exclusively Breastfed Newborns: Prospective, Randomized, Double‐Blind, Placebo‐Controlled Trial
title_full Effect of Oral Vitamin D3 Supplementation in Exclusively Breastfed Newborns: Prospective, Randomized, Double‐Blind, Placebo‐Controlled Trial
title_fullStr Effect of Oral Vitamin D3 Supplementation in Exclusively Breastfed Newborns: Prospective, Randomized, Double‐Blind, Placebo‐Controlled Trial
title_full_unstemmed Effect of Oral Vitamin D3 Supplementation in Exclusively Breastfed Newborns: Prospective, Randomized, Double‐Blind, Placebo‐Controlled Trial
title_short Effect of Oral Vitamin D3 Supplementation in Exclusively Breastfed Newborns: Prospective, Randomized, Double‐Blind, Placebo‐Controlled Trial
title_sort effect of oral vitamin d3 supplementation in exclusively breastfed newborns: prospective, randomized, double‐blind, placebo‐controlled trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306990/
https://www.ncbi.nlm.nih.gov/pubmed/35122668
http://dx.doi.org/10.1002/jbmr.4521
work_keys_str_mv AT linchaohsu effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT linchienyu effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT sungyihsiang effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT lisungtse effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT chengbiwen effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT wengshunlong effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT changshingjyh effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT leehungchang effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT leeyannjinn effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT tingweihsin effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT changhungyang effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT wuyilei effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial
AT linchihsheng effectoforalvitamind3supplementationinexclusivelybreastfednewbornsprospectiverandomizeddoubleblindplacebocontrolledtrial